Effects of behavioral activation program without psychotropic medication treatment for depression in late adolescence: case report
Received 13 March 2018
Accepted for publication 18 June 2018
Published 27 August 2018 Volume 2018:14 Pages 2159—2164
Checked for plagiarism Yes
Review by Single-blind
Peer reviewer comments 3
Editor who approved publication: Dr Taro Kishi
Koki Takagaki,1 Yasumasa Okamoto,1 Ran Jinnin,1 Satoshi Yokoyama,1 Atsuo Yoshino,1 Fumi Kagawa,1 Yuri Okamoto,2 Yoshie Miyake,2 Shigeto Yamawaki1
1Department of Psychiatry and Neurosciences, Hiroshima University, Hiroshima, Japan; 2Health Service Center, Hiroshima University, Hiroshima, Japan
Background: A Japanese study revealed that 20.7% of first-year undergraduate students had a major depressive episode during the previous 12 months: first-year undergraduate students with depression need early support. Reportedly, antidepressant medication use during adolescence is associated with modestly increased risk of suicidality. This case study of a late-adolescent woman with depression illustrates the effects of behavioral activation without psychotropic medication.
Case presentation: A first-year undergraduate student was diagnosed as having major depressive disorder. From earlier studies, we developed a behavioral activation program for late-adolescent people with major depressive disorder. Behavioral activation administered in 10 weekly 60-minute sessions decreased depressive symptoms, avoidant behaviors, and rumination. Moreover, the Beck Depression Inventory, second version score was 1 at 1-year follow-up.
Conclusion: Results of this case study show that behavioral activation is effective without psychotropic medication. Future studies of large samples must be conducted to assess the effectiveness of behavioral activation without psychotropic medication for depression in late adolescence.
Keywords: avoidant behavior, behavioral activation without psychotropic medication, major depressive symptoms, rumination
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]